66 results
Page 2 of 4
6-K
EX-99.1
s55y0ft7
6 Oct 21
Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
6:00am
6-K
EX-99.1
ikhrv lob
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.2
p0jpe2xn01
5 Aug 21
Galapagos reports H1 financial results with refocused pipeline and operational progress
4:02pm
6-K
EX-99.1
areeqckpw4 9issio
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.3
rtx9ley ndka24tejrn
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.2
evpf2
11 May 21
Current report (foreign)
2:10pm
6-K
EX-99.1
olusdred28o
19 Feb 21
Pipeline and capital for growth
6:00am
6-K
EX-99.1
0oxd0
15 Dec 20
Current report (foreign)
4:55pm
6-K
EX-99.2
viecg tskvt6zx3cb1s
9 Nov 20
Galapagos reports Q3 2020 results
4:01pm
6-K
EX-99.1
dv4kkdsovdx5plm
3 Nov 20
Current report (foreign)
6:00am
6-K
EX-99.1
m6ch23yd iit2t
13 Oct 20
Current report (foreign)
6:15am
6-K
EX-99.1
mq20d qe9x
28 Sep 20
Current report (foreign)
6:00am
6-K
EX-99.1
ax1l5dd9
19 Aug 20
Current report (foreign)
6:00am
6-K
EX-99.2
u5y fsm58ybbw0tb
6 Aug 20
Galapagos reports solid H1 2020 progress
4:01pm
6-K
EX-99.1
f2swyslifehym
24 Jul 20
Current report (foreign)
9:45am
6-K
EX-99.1
t8ielqoqfjy p1su6h3d
8 Jun 20
Current report (foreign)
6:00am
6-K
EX-99.1
gsi38o 3a4h
4 Jun 20
Current report (foreign)
11:01am
6-K
EX-99.1
lb2h08
26 May 20
Gilead and Galapagos Announce Positive Topline Results of Phase 2B/3 Trial of Filgotinib In Moderately to Severely Active Ulcerative Colitis
6:10am
6-K
EX-99.2
njxu2oapx6r8 fda
11 May 20
Current report (foreign)
4:05pm